Applied Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Applied Therapeutics

10/08/2023 14:32

* Applied Therapeutics Inc  APLT.OQ  reported a quarterly
adjusted
loss of 37 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 26 cents per share.
    * Reported revenue was zero​; analysts expected $8.00
million. 
    * Applied Therapeutics Inc's reported EPS for the quarter
was a
loss of 37 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Applied Therapeutics Inc shares had risen by 21.9% this
quarter and gained 105.3% so far this year.
    * The company reported a quarterly loss of $29.58 million.
    * Wall Street's median 12-month price target for Applied
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.26          -0.37          Missed
 Mar. 31 2023      -0.31          -0.18          Beat
 Dec. 31 2022      -0.46          -0.16          Beat
 Sep. 30 2022      -0.48          -0.40          Beat